A. Clarke et al., INDICATIONS FOR AND OUTCOME OF TOTAL ABDOMINAL HYSTERECTOMY FOR BENIGN DISEASE - A PROSPECTIVE COHORT STUDY, British journal of obstetrics and gynaecology, 102(8), 1995, pp. 611-620
Objective To describe the indications for total abdominal hysterectomy
for women with nonmalignant disease and to determine the immediate (i
nitial ten days) and medium term outcome. Design A prospective cohort
study. Setting Three district general hospitals in shire counties, two
in outer London and one London teaching hospital. Subjects Three hund
red and sixty-six women undergoing total abdominal hysterectomy (with
or without other procedures) for nonmalignant disease. Interventions S
elf-completed patient questionnaires before and ten days, six weeks an
d three months after surgery. Data extracted from patients' hospital c
ase notes. Main outcome measures Complications plus change in symptoms
, urinary and bowel function, general health status, sexual function,
activities of daily living and quality of life. Results The principal
indications were bleeding, pain or both. Symptoms were severe enough t
o be socially debilitating and have a major impact on lifestyle. Other
wise, the women were in good health. During the first ten post-operati
ve days the women suffered more pain, urinary discomfort, constipation
and a reduction in their ability to perform activities of daily livin
g. Urinary (25%) and wound (25%) infections were the commonest complic
ations. At the same time, significant improvements in psychological he
alth occurred. By six weeks, the principal symptoms had resolved for 9
5% of the women and early adverse effects on urinary and bowel functio
n had settled. This was reflected in improvements in health status and
quality of life including sexual activity. Despite this, these change
s did not meet the pre-operative expectations of some women. Conclusio
ns Most women reported substantial benefits from hysterectomy. However
, women should be warned about early, transient adverse effects. These
findings can serve as a benchmark for nonexperimental evaluations of
the effectiveness of new treatment modalities.